BRIDGEWATER, England, September 9 /PRNewswire/ -- Clinical Therapeutics,( http://www.clinicaltherapeutics.com/) the world's premier, rapid-publication journal, is proud to announce the addition of Michael G. Spigarelli, MD, PhD, to our distinguished editorial board.
As section editor for the Pediatric, Adolescent, & Maternal Therapeutics
(http://www.clinicaltherapeutics.com/ped.html) section (formerly the
Pediatric Research section), Dr. Spigarelli brings a wealth of knowledge and
a strong background in addressing the issues surrounding these special
populations. He completed his residency in internal medicine and pediatrics
Pregnant women and children remain among the most vulnerable patients undergoing therapy today due to a lack of critical information on the safety, tolerability, and efficacy of pharmacotherapies indicated for them. As Dr. Spigarelli states in his inaugural editorial, "To date, most medications used in the treatment of illness in children have never been tested in them.... This lack of crucial information has important implications for a variety of stakeholders."
By refocusing the Pediatric, Adolescent, & Maternal Therapeutics (http://www.clinicaltherapeutics.com/ped.html) section, Clinical Therapeutics(http://www.clinicaltherapeutics.com/) seeks to become the premier venue for publication of clinical research in these special populations and serve as an international forum for the timely discussion of safe and effective drug therapies in neonates, infants, children, adolescents, and pregnant or lactating women.
"As Editor of this section, I encourage each of you to review your files for data already obtained but not yet published, for data from ongoing studies, and consider submitting those manuscripts to Clinical Therapeutics. Each additional piece of available data adds to the knowledge base needed to provide the best health care for pregnant women and children."
An example of important pediatric information published by the journal is the supplemental issue on Conquering Pain: The Hidden Cost of Immunization sponsored by the Canadian Institutes of Health Research and the SickKids Foundation. Also highlighting the journal's commitment to fostering publication of scientific research related to these special populations is the upcoming focus issue on vaccines.
For more information about this press release and Clinical Therapeutics, contact Julie E. Artim at:
Phone: +44(0)908-547-2094 Email: ELSRapidPubs@Elsevier.com Website: ElsRapidPubs.com
|SOURCE Clinical Therapeutics|
Copyright©2009 PR Newswire.
All rights reserved